Be Ready to Handle Rxs for the New COPD Drug, Yupelri

April 2019

Rx Yupelri (yoo-PEL-ree) will be a new nebulized med for COPD.

Think of Yupelri (revefenacin) as an alternative to Lonhala Magnair (glycopyrrolate). They're both long-acting "anticholinergics" given via a nebulizer...and each costs about $1,000 per month.

But there are a few differences that will give Yupelri an edge.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Veterinary Medicine Follow Safeguards When Dispensing Controlled Substances for Pets
Measles Help Identify Patients Needing Measles Vaccines
COPD Be Ready to Handle Rxs for the New COPD Drug, Yupelri
Edema Look for Meds That Can Cause Swelling in the Legs or Arms
Med Safety Prevent Mix-Ups With Sublingual Nitroglycerin
Ulcerative Colitis Know How Meds for Ulcerative Colitis Stack Up
Migraine Help Keep Kids Safe While Taking Migraine Meds
OTC Products Navigate Through Miralax and Other Rx-to-OTC Switches
Hyperkalemia Think of Lokelma as Similar to Kayexalate or Veltassa for High Potassium
Anxiety Stay Alert for Common Errors With Anxiety Meds
Oral Health Demystify Magic Mouthwash Rxs

Be Ready to Handle Rxs for the New COPD Drug, Yupelri

Practical advice for a better career, with unlimited access to CE

Table of Contents